Home

VHCP Management III, LLC

CIK 1738053 · last filed 2024-02-01

VHCP Management III, LLC is a corporate insider who has filed 14 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing shows the insider bought $8.9M of KALV on Feb 1, 2024. Across all open-market trades the lifetime net is +$345.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $12.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.78M

Companies

5

Total Filings

14

Lifetime Open-Market Net

$345.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KalVista Pharmaceuticals, Inc. (KALV) Delisted 10%+ Owner 4,738,683 $27.00 $127.94M $11.26M 2 2024-02-01
Tricida, Inc. (TCDA) Delisted 10%+ Owner 8,088,998 $0.11 $873.6K $43.29M 6 2022-10-26
ALT 10%+ Owner 4,500,000 $2.84 $12.78M $181.64M 2 2020-06-15
CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted 10%+ Owner 4,016,873 $33.99 $136.53M $110.40M 1 2019-12-16
Bellerophon Therapeutics, Inc. (BLPH) Delisted 10%+ Owner 429,012 $0.01 $5.1K -$1.43M 3 2019-10-28

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-02-01 KalVista Pharmaceuticals, Inc. (KALV) Delisted Buy (P) +616,693 $8.92M EDGAR
2024-01-16 KalVista Pharmaceuticals, Inc. (KALV) Delisted Buy (P) +183,722 $2.34M EDGAR
2022-10-26 Tricida, Inc. (TCDA) Delisted Sell (S) −64,515,400 -$35.02M EDGAR
2022-10-03 Tricida, Inc. (TCDA) Delisted Buy (P) +4,369,230 $46.97M EDGAR
2022-07-25 Tricida, Inc. (TCDA) Delisted Buy (P) +741,990 $6.87M EDGAR
2022-07-20 Tricida, Inc. (TCDA) Delisted Buy (P) +1,500,000 $13.77M EDGAR
2022-06-21 Tricida, Inc. (TCDA) Delisted Buy (P) +59,510 $576.7K EDGAR
2022-06-14 Tricida, Inc. (TCDA) Delisted Buy (P) +1,180,540 $10.11M EDGAR
2020-06-15 ALT Buy (P) +12,000,000 $90.48M EDGAR
2020-05-28 ALT Buy (P) +10,429,088 $91.16M EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.